Management of gout.
Although the traditional oral colchicine regimen is often used for the acute attack, the intravenous route has advantages. Indomethacin, phenylbutazone, oxyphenbutazone and the newer nonsteroidal anti-inflammatory agents, such as ibuprofen, naproxen and fenoprofen, are quite successful. For chronic management of hyperuricemia, it is helpful to distinguish between overproducers of uric acid, for whom allopurinol is the rational therapy, and underexcreters of uric acid, for whom probenecid or sulfinpyrazone is indicated.
D000493:Allopurinol / Q000008:administration & dosage / Q000627:therapeutic use; D003078:Colchicine / Q000008:administration & dosage / Q000627:therapeutic use; D006073:Gout / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D010653:Phenylbutazone / Q000627:therapeutic use; D011339:Probenecid / Q000627:therapeutic use; D013442:Sulfinpyrazone / Q000627:therapeutic use
D000493:Allopurinol; D010653:Phenylbutazone; D011339:Probenecid; D003078:Colchicine; D013442:Sulfinpyrazone